We are traded on the Nasdaq Capital Market under the ticker symbol “OKUR”, and our CUSIP number is 68277Q 105.
We are incorporated in the State of Delaware.
The reverse merger between OnKure, Inc. (“Former OnKure”) and OnKure Therapeutics, Inc. (formerly, Reneo Pharmaceuticals, Inc.) closed on October 4, 2024.
Our fiscal year end is December 31.
Shares of OnKure Therapeutic's stock can be purchased by contacting a securities broker of your choice.
Our transfer agent is:
American Stock Transfer & Trust Company, LLC
Phone (U.S.): (800) 937-5449
6201 15th Ave.
Brooklyn, N.Y. 11219
Click here to review our investor contact information.
For RPHM shareholders as of October 4, 2024, the attached IRS Form 8937 – 2024.10.04 provides details to assist you with calculating the cost basis of your investment and tax impact of any fractional share payments for tax purposes.
For OnKure, Inc. shareholders as of October 4, 2024, the attached IRS Form 8937 – 2024.10.04 provides details to assist you with calculating the cost basis of your investment for tax purposes.